Researchers working on an incurable blood cancer can now use a new lab model that could make testing potential new treatments ...

Prostate cancer is a significant health concern for men globally, with rising incidence and mortality rates. Early detection ...

Thermo Fisher Scientific, the world leader in serving science, today announced the U.S. Food and Drug Administration (FDA) ...

Scientists with the NIH-backed SMaHT Network are mapping every DNA mutation in the human body, creating a groundbreaking ...

Patients with ovarian clear cell carcinoma (OCCC) whose tumors have specific mutations in the PPP2R1A gene were found to have improved survival following immunotherapy compared to patients without ...

The approval of sunvozertinib, an oral irreversible EGFR inhibitor, was supported by data from the WU-KONG1B trial (ClinicalTrials.gov Identifier: NCT03974022 ). The primary efficacy population ...

Researchers say never-smokers living in more polluted cities have significantly more mutations linked to malignancy ...

Researchers working on an incurable blood cancer can now use a new lab model which could make testing potential new ...

Wristband that provides relief for upper limb tremor is approved; FDA warns of clinically significant weight loss in younger kids taking ADHD meds; REMS removed for CAR T-cell immunotherapies; ...

Zegfrovy is designed to target a broad range of EGFR mutations while maintaining selectivity over wild-type EGFR.

The US Food and Drug Administration has granted accelerated approval to sunvozertinib (trade name Zegfrovy) from Dizal ...

A new study has found that people who don't smoke can still get lung cancer due to things like air pollution, harmful chemicals, and certain traditional herbal medicines.'We're ...